Interleukin 2 receptor antagonists for kidney transplant recipients

BACKGROUND: Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, but the proportion of new transplant recipients receiving IL2Ra differs around t...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cochrane Database Syst Rev
Päätekijät: Webster, Angela C, Ruster, Lorenn P, McGee, Richard G, Matheson, Sandra L, Higgins, Gail Y, Willis, Narelle S, Chapman, Jeremy R, Craig, Jonathan C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2010
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154335/
https://ncbi.nlm.nih.gov/pubmed/20091551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003897.pub3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia